Organogenesis Holdings Inc.·4

Feb 20, 5:26 PM ET

Quintero Gilberto 4

Research Summary

AI-generated summary

Updated

Organogenesis (ORGO) Director Gilberto Quintero Receives RSU Award

What Happened

  • Gilberto Quintero, a director of Organogenesis Holdings Inc. (ORGO), received an award of 48,828 restricted stock units (RSUs) on February 18, 2026. The units were reported with an acquisition price of $0.00. Each RSU represents the contingent right to one share of Organogenesis Class A common stock and the RSUs vest in full on February 15, 2027.
  • This is an equity award (transaction code A), not an open-market purchase or sale. Awards are common as compensation or incentive and do not represent an immediate cash outlay or sale.

Key Details

  • Transaction date: 2026-02-18; Form 4 filed: 2026-02-20 (timely filing).
  • Award: 48,828 RSUs; reported acquisition price: $0.00.
  • Vesting: RSUs vest in full on February 15, 2027 (see footnote).
  • Shares owned after transaction: not disclosed on the provided excerpt.
  • Footnote: Each RSU converts to one share of Class A common stock upon vesting.

Context

  • RSU grants are a compensation tool and do not necessarily indicate the insider is buying or selling stock; value to the insider is realized only if and when the RSUs vest and convert to shares (and then may be taxable).
  • Because this is an award (not a sale), it’s generally less informative about the director’s near-term market view than open-market purchases or sales.